Back to search results

Personalized Support for Menopausal Individuals with Dementia Risk

This study is developing a personalized support program called PERI-MIND for women aged 40-58 who are going through menopause and have a higher risk of dementia, such as having a close family member with Alzheimer's disease. The program aims to help with fears and worries about dementia during menopause. PERI-MIND will include education, coping strategies, and activities to improve well-being. Researchers will measure how many participants complete the study and how acceptable the program content is. The study plans to enroll 60 participants. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 60 women. It is developing a personalized behavioral intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from enrollment until pilot testing is completed.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06965686

Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk

Recruiting
NAAges 40–58InterventionalSupportive care
University of Chicago
~60 participants
Updated 2026-02-05 on ClinicalTrials.gov
What's tested:PERI-MIND

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants who are enrolled and complete the study
Measured over From enrollment until pilot testing is completed
+1 more outcome measured

Conditions

Menopausal
Dementia

Explore related trials

DementiaMenopause present

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Francesca Farina, PhD · PRINCIPAL_INVESTIGATOR · University of Chicago

Who to contact

Grace Bardwick, MPH
[email protected]
773-702-1972
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female sex at birth
Aged between 40-58 years
Late perimenopause or early post-menopause
Elevated dementia risk characterized by first degree relative with diagnosis of Alzheimer's disease or another dementia

Exclusion

Diagnosis of Mild Cognitive Impairment, Alzheimer's or another dementia
Diagnosis of other chronic illness or condition that affects cognition (e.g., Axis I psychiatric disorders such as schizophrenia or mood disorders, neurological disorders such as stroke, cancer, traumatic brain injury)
Inadequate vision or hearing to engage with intervention materials
Unable or unwilling to provide informed consent
Iatrogenic menopause (i.e., due to surgery)

What this trial measures

  • Number of participants who are enrolled and complete the studyFrom enrollment until pilot testing is completed

    Feasibility outcomes will relate to the successful implementation and completion of the intervention, including the ease of recruitment and ability of participants to enroll and complete the study. Metrics will include the total number of participants identified and enrolled in the study and completion rate.

  • Acceptability of intervention contentFrom enrollment until pilot testing is completed

    Acceptability will be assessed using standard Likert-type scales, informed by the Theoretical Framework of Acceptability for healthcare interventions. Questions will focus on the content, presentation format and length.